bpc+157 BPC-157 Peptide Therapy BPC 157 | Gastric Pentadecapeptide

Prefer the specific X-modifiers when they apply

Cellular Energy NAD+ & Sirtuines NAD+ Restoration & Mitochondrial Function By preserving the NAD+ pool, 5-Amino-1MQ supports the mitochondrial electron transport chain and the activation of sirtuins (SIRT1-7)

8, 6th Annual Payers' Guide

BPC-157 + TB-500 is a research peptide blend combining two synthetic peptides studied in laboratory research involving peptide chemistry, molecular signaling, protein interactions, cellular communication, and controlled experimental models

Community cycle math using 5 mg vials Cycle length 8 weeks 300 mcg phase 28 days 0.3 mg = 8.4 mg 500 mcg phase 28 days 0.5 mg = 14 mg Total amount 22.4 mg 5 mg vials 5 vials Cycle length 12 weeks 300 mcg phase 28 days 0.3 mg = 8.4 mg 500 mcg phase 56 days 0.5 mg = 28 mg Total amount 36.4 mg 5 mg vials 8 vials Cycle length 16 weeks 300 mcg phase 28 days 0.3 mg = 8.4 mg 500 mcg phase 84 days 0.5 mg = 42 mg Total amount 50.4 mg 5 mg vials 11 vials Vial counts are rounded up to the next full 5 mg vial

Tendon injuries that respond best to BPC-157 are listed below